US 7332281
Therapeutic targets in cancer
granted A61PA61P35/00A61P35/02
Quick answer
US patent 7332281 (Therapeutic targets in cancer) held by Sagres Discovery, Inc. expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sagres Discovery, Inc.
- Grant date
- Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00